[go: up one dir, main page]

Garces, 2010 - Google Patents

BK virus–associated nephropathy in kidney transplant recipients

Garces, 2010

View PDF
Document ID
381661011829700199
Author
Garces J
Publication year
Publication venue
Ochsner Journal

External Links

Snippet

BK virus was first isolated in 1970 from a kidney transplant recipient with a ureteric stricture. Epidemiologic studies have shown that up to 90% of some human populations become exposed to BK virus by adulthood. After kidney transplant, 10% to 60% of patients excrete …
Continue reading at www.ochsnerjournal.org (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics

Similar Documents

Publication Publication Date Title
Kotton et al. The second international consensus guidelines on the management of BK polyomavirus in kidney transplantation
Bechert et al. Monitoring of BK viral load in renal allograft recipients by real-time PCR assays
Babel et al. BK polyomavirus infection and nephropathy: the virus–immune system interplay
Hirsch et al. European perspective on human polyomavirus infection, replication and disease in solid organ transplantation
Nasrallah et al. Seroprevalence of hepatitis E virus among blood donors in Qatar (2013‐2016)
Natori et al. Use of viral load as a surrogate marker in clinical studies of cytomegalovirus in solid organ transplantation: a systematic review and meta-analysis
Hirsch et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations
Nickeleit et al. Polyomavirus nephropathy in native kidneys and renal allografts: an update on an escalating threat
Chung et al. Clinical usefulness of BK virus plasma quantitative PCR to prevent BK virus associated nephropathy
Hayden et al. Risk factors for hemorrhagic cystitis in pediatric allogeneic hematopoietic stem cell transplant recipients
Theodoropoulos et al. BK virus replication and nephropathy after alemtuzumab-induced kidney transplantation
Waldman et al. Parvovirus-B19-associated complications in renal transplant recipients
Nankivell et al. Clinical utility of urinary cytology to detect BK viral nephropathy
Kantarci et al. JC virus‐associated nephropathy in a renal transplant recipient and comparative analysis of previous cases
Masutani et al. Putative episodes of T-cell–mediated rejection in patients with sustained BK viruria but no viremia
Funahashi BK virus-associated nephropathy after renal transplantation
Tripathy et al. Hepatitis E virus seroprevalence among blood donors in Pune, India
Imlay et al. Clinical characteristics and outcomes of late‐onset BK virus nephropathy in kidney and kidney‐pancreas transplant recipients
Muhsin et al. BK virus in transplant recipients: current perspectives
Korth et al. Impact of low‐level BK polyomavirus viremia on intermediate‐term renal allograft function
Murray et al. Visualization of West Nile virus in urine sediment using electron microscopy and immunogold up to nine years postinfection
Garces BK virus–associated nephropathy in kidney transplant recipients
Spinelli et al. Hepatitis C virus and risk of non‐Hodgkin lymphoma in British Columbia, Canada
Katsolis et al. Evaluation of risk factors for cytomegalovirus infection and disease occurring within 1 year of liver transplantation in high‐risk patients
White et al. BK virus nephropathy in renal transplant patients in London